Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 145

1.

Knockout of LASP1 in CXCR4 expressing CML cells promotes cell persistence, proliferation and TKI resistance.

Herrmann AB, Müller ML, Orth MF, Müller JP, Zernecke A, Hochhaus A, Ernst T, Butt E, Frietsch JJ.

J Cell Mol Med. 2020 Mar;24(5):2942-2955. doi: 10.1111/jcmm.14910. Epub 2020 Jan 19.

2.

Emerging therapies in transthyretin amyloidosis - a new wave of hope after years of stagnancy?

Müller ML, Butler J, Heidecker B.

Eur J Heart Fail. 2020 Jan;22(1):39-53. doi: 10.1002/ejhf.1695. Epub 2020 Jan 7. Review.

PMID:
31912620
3.

Rotavirus vaccination in the neonatal intensive care units: where are we? A rapid review of recent evidence.

Sicard M, Bryant K, Muller ML, Quach C.

Curr Opin Pediatr. 2020 Feb;32(1):167-191. doi: 10.1097/MOP.0000000000000869.

PMID:
31851055
4.

Apathy rating scores and β-amyloidopathy in patients with Parkinson disease at risk for cognitive decline.

Zhou Z, Müller MLTM, Kanel P, Chua J, Kotagal V, Kaufer DI, Albin RL, Frey KA, Bohnen NI.

Neurology. 2020 Jan 28;94(4):e376-e383. doi: 10.1212/WNL.0000000000008683. Epub 2019 Nov 15.

PMID:
31732566
5.

Treatment options for postural instability and gait difficulties in Parkinson's disease.

Müller MLTM, Marusic U, van Emde Boas M, Weiss D, Bohnen NI.

Expert Rev Neurother. 2019 Dec;19(12):1229-1251. doi: 10.1080/14737175.2019.1656067. Epub 2019 Aug 30.

PMID:
31418599
6.

Cholinergic system changes of falls and freezing of gait in Parkinson's disease.

Bohnen NI, Kanel P, Zhou Z, Koeppe RA, Frey KA, Dauer WT, Albin RL, Müller MLTM.

Ann Neurol. 2019 Apr;85(4):538-549. doi: 10.1002/ana.25430. Epub 2019 Mar 13.

7.

Erratum zu: Nichtoperative und operative Behandlung der osteoporotischen Wirbelkörperfraktur : Empfehlungen der Sektion Wirbelsäule der Deutschen Gesellschaft für Orthopädie und Unfallchirurgie (DGOU).

Blattert TR, Schnake KJ, Gonschorek O, Katscher S, Ullrich BW, Gercek E, Hartmann F, Mörk S, Morrison R, Müller ML, Partenheimer A, Piltz S, Scherer MA, Verheyden A, Zimmermann V; Sektion Wirbelsäule der Deutschen Gesellschaft für Orthopädie und Unfallchirurgie.

Orthopade. 2019 Feb;48(2):175. doi: 10.1007/s00132-019-03689-7. German. No abstract available.

PMID:
30666342
8.

Multimodal dopaminergic and free-water imaging in Parkinson's disease.

Yang J, Archer DB, Burciu RG, Müller MLTM, Roy A, Ofori E, Bohnen NI, Albin RL, Vaillancourt DE.

Parkinsonism Relat Disord. 2019 May;62:10-15. doi: 10.1016/j.parkreldis.2019.01.007. Epub 2019 Jan 6.

PMID:
30639168
9.

[Nonsurgical and surgical management of osteoporotic vertebral body fractures : Recommendations of the Spine Section of the German Society for Orthopaedics and Trauma (DGOU)].

Blattert TR, Schnake KJ, Gonschorek O, Katscher S, Ullrich BW, Gercek E, Hartmann F, Mörk S, Morrison R, Müller ML, Partenheimer A, Piltz S, Scherer MA, Verheyden A, Zimmermann V; die Sektion Wirbelsäule der Deutschen Gesellschaft für Orthopädie und Unfallchirurgie.

Orthopade. 2019 Jan;48(1):84-91. doi: 10.1007/s00132-018-03666-6. Review. German. Erratum in: Orthopade. 2019 Jan 21;:.

PMID:
30574674
10.

Targeting the pedunculopontine nucleus in Parkinson's disease: Time to go back to the drawing board.

Albin RL, Surmeier DJ, Tubert C, Sarter M, Müller MLTM, Bohnen NI, Dauer WT.

Mov Disord. 2018 Dec;33(12):1871-1875. doi: 10.1002/mds.27540. Epub 2018 Nov 6. Review. No abstract available.

11.

Molecular Imaging of the Cholinergic System in Parkinson's Disease.

Bohnen NI, Kanel P, Müller MLTM.

Int Rev Neurobiol. 2018;141:211-250. doi: 10.1016/bs.irn.2018.07.027. Epub 2018 Sep 20. Review.

12.

Regional vesicular acetylcholine transporter distribution in human brain: A [18 F]fluoroethoxybenzovesamicol positron emission tomography study.

Albin RL, Bohnen NI, Muller MLTM, Dauer WT, Sarter M, Frey KA, Koeppe RA.

J Comp Neurol. 2018 Dec 1;526(17):2884-2897. doi: 10.1002/cne.24541. Epub 2018 Oct 19.

13.

Quantification of brain cholinergic denervation in dementia with Lewy bodies using PET imaging with [18F]-FEOBV.

Nejad-Davarani S, Koeppe RA, Albin RL, Frey KA, Müller MLTM, Bohnen NI.

Mol Psychiatry. 2019 Mar;24(3):322-327. doi: 10.1038/s41380-018-0130-5. Epub 2018 Aug 6. No abstract available.

14.

Neurotransmitter amines and antioxidant agents in neuronal protection against methylmercury-induced cytotoxicity in primary cultures of mice cortical neurons.

Olguín N, Müller ML, Rodríguez-Farré E, Suñol C.

Neurotoxicology. 2018 Dec;69:278-287. doi: 10.1016/j.neuro.2018.07.020. Epub 2018 Jul 31.

PMID:
30075218
15.

Model-based and Model-free Machine Learning Techniques for Diagnostic Prediction and Classification of Clinical Outcomes in Parkinson's Disease.

Gao C, Sun H, Wang T, Tang M, Bohnen NI, Müller MLTM, Herman T, Giladi N, Kalinin A, Spino C, Dauer W, Hausdorff JM, Dinov ID.

Sci Rep. 2018 May 8;8(1):7129. doi: 10.1038/s41598-018-24783-4.

16.

Peripheral neuropathy is associated with more frequent falls in Parkinson's disease.

Beaulieu ML, Müller MLTM, Bohnen NI.

Parkinsonism Relat Disord. 2018 Sep;54:46-50. doi: 10.1016/j.parkreldis.2018.04.006. Epub 2018 Apr 3.

17.

A RAB27A 5' untranslated region structural variant associated with late-onset hemophagocytic lymphohistiocytosis and normal pigmentation.

Tesi B, Rascon J, Chiang SCC, Burnyte B, Löfstedt A, Fasth A, Heizmann M, Juozapaite S, Kiudeliene R, Kvedaraite E, Miseviciene V, Muleviciene A, Müller ML, Nordenskjöld M, Matuzeviciene R, Samaitiene R, Speckmann C, Stankeviciene S, Zekas V, Voss M, Ehl S, Vaiciene-Magistris N, Henter JI, Meeths M, Bryceson YT.

J Allergy Clin Immunol. 2018 Jul;142(1):317-321.e8. doi: 10.1016/j.jaci.2018.02.031. Epub 2018 Mar 6. No abstract available.

18.

Recent advances in cholinergic imaging and cognitive decline-Revisiting the cholinergic hypothesis of dementia.

Bohnen NI, Grothe MJ, Ray NJ, Müller MLTM, Teipel SJ.

Curr Geriatr Rep. 2018 Mar;7(1):1-11. doi: 10.1007/s13670-018-0234-4. Epub 2018 Jan 13.

19.

Cardiovascular Risk Factor Burden in Veterans and Non-Veterans with Parkinson Disease.

Kotagal V, Albin RL, Müller MLTM, Bohnen NI.

J Parkinsons Dis. 2018;8(1):153-160. doi: 10.3233/JPD-171271.

20.

Compensatory dopaminergic-cholinergic interactions in conflict processing: Evidence from patients with Parkinson's disease.

Kim K, Bohnen NI, Müller MLTM, Lustig C.

Neuroimage. 2019 Apr 15;190:94-106. doi: 10.1016/j.neuroimage.2018.01.021. Epub 2018 Jan 11.

PMID:
29337277
21.

The cortical cholinergic system contributes to the top-down control of distraction: Evidence from patients with Parkinson's disease.

Kim K, Müller MLTM, Bohnen NI, Sarter M, Lustig C.

Neuroimage. 2019 Apr 15;190:107-117. doi: 10.1016/j.neuroimage.2017.12.012. Epub 2017 Dec 19.

PMID:
29277400
22.

Dopaminergic polymorphisms associated with medication responsiveness of gait in Parkinson's disease.

Miller NS, Chou KL, Bohnen NI, Müller MLTM, Seidler RD.

Parkinsonism Relat Disord. 2018 Mar;48:54-60. doi: 10.1016/j.parkreldis.2017.12.010. Epub 2017 Dec 12.

23.

Color discrimination errors associate with axial motor impairments in Parkinson's disease.

Bohnen NI, Haugen J, Ridder A, Kotagal V, Albin RL, Frey KA, Müller MLTM.

Mov Disord Clin Pract. 2017 Nov-Dec;4(6):864-869. doi: 10.1002/mdc3.12527. Epub 2017 Sep 8.

24.

Molecular Imaging and Updated Diagnostic Criteria in Lewy Body Dementias.

Bohnen NI, Müller MLTM, Frey KA.

Curr Neurol Neurosci Rep. 2017 Aug 14;17(10):73. doi: 10.1007/s11910-017-0789-z. Review.

25.

Mentally stimulating activities associate with better cognitive performance in Parkinson disease.

Bohnen JLB, Müller MLTM, Haugen J, Bohnen NI.

J Neural Transm (Vienna). 2017 Oct;124(10):1205-1212. doi: 10.1007/s00702-017-1761-4. Epub 2017 Jul 19.

26.

Have we been overestimating fall rates in Parkinson's disease?

Beaulieu ML, Müller MLTM, Bohnen NI.

Mov Disord. 2017 May;32(5):803. doi: 10.1002/mds.26994. Epub 2017 Apr 21. No abstract available.

27.

Evidence of Intercontinental Spread and Uncommon Variants of Low-Pathogenicity Avian Influenza Viruses in Ducks Overwintering in Guatemala.

Gonzalez-Reiche AS, Nelson MI, Angel M, Müller ML, Ortiz L, Dutta J, van Bakel H, Cordon-Rosales C, Perez DR.

mSphere. 2017 Apr 5;2(2). pii: e00362-16. doi: 10.1128/mSphere.00362-16. eCollection 2017 Mar-Apr.

28.

Thalamic cholinergic innervation makes a specific bottom-up contribution to signal detection: Evidence from Parkinson's disease patients with defined cholinergic losses.

Kim K, Müller MLTM, Bohnen NI, Sarter M, Lustig C.

Neuroimage. 2017 Apr 1;149:295-304. doi: 10.1016/j.neuroimage.2017.02.006. Epub 2017 Feb 5.

29.

Nontyphoidal Salmonella Osteomyelitis in Immunocompetent Children Without Hemoglobinopathies: A Case Series and Systematic Review of the Literature.

Gill AN, Muller ML, Pavlik DF, Eldredge JD, Johnston JJ, Eickman MM, Dehority W.

Pediatr Infect Dis J. 2017 Sep;36(9):910-912. doi: 10.1097/INF.0000000000001555. Review.

PMID:
28134744
30.

Cerebral Amyloid Burden and Hoehn and Yahr Stage 3 Scoring in Parkinson Disease.

Kotagal V, Bohnen NI, Müller ML, Frey KA, Albin RL.

J Parkinsons Dis. 2017;7(1):143-147. doi: 10.3233/JPD-160985.

31.

LFA-1 Activation in NK Cells and Their Subsets: Influence of Receptors, Maturation, and Cytokine Stimulation.

Urlaub D, Höfer K, Müller ML, Watzl C.

J Immunol. 2017 Mar 1;198(5):1944-1951. doi: 10.4049/jimmunol.1601004. Epub 2017 Jan 18.

32.

Origin, distribution, and potential risk factors associated with influenza A virus in swine in two production systems in Guatemala.

Gonzalez-Reiche AS, Ramírez AL, Müller ML, Orellana D, Sosa SM, Ola P, Paniagua J, Ortíz L, Hernandez J, Cordón-Rosales C, Perez DR.

Influenza Other Respir Viruses. 2017 Mar;11(2):182-192. doi: 10.1111/irv.12437. Epub 2017 Jan 30.

33.

Impaired contrast sensitivity is associated with more severe cognitive impairment in Parkinson disease.

Ridder A, Müller ML, Kotagal V, Frey KA, Albin RL, Bohnen NI.

Parkinsonism Relat Disord. 2017 Jan;34:15-19. doi: 10.1016/j.parkreldis.2016.10.006. Epub 2016 Oct 7.

34.

Cerebral small vessel disease and incident parkinsonism: the RUN DMC study.

Bohnen NI, Muller ML.

Neurology. 2016 Mar 29;86(13):1268-9. No abstract available.

PMID:
27471769
35.

Prevalence and Diversity of Low Pathogenicity Avian Influenza Viruses in Wild Birds in Guatemala, 2010-2013.

Gonzalez-Reiche AS, Müller ML, Ortiz L, Cordón-Rosales C, Perez DR.

Avian Dis. 2016 May;60(1 Suppl):359-64. doi: 10.1637/11130-050715-Reg.

36.

Is normosmic Parkinson disease a unique clinical phenotype?

Bohnen NI, Muller ML, Sohn YH, Lee DH.

Neurology. 2016 Apr 26;86(17):1649-50. doi: 10.1212/WNL.0000000000002647. No abstract available.

PMID:
27164644
37.

Dementia with Lewy bodies can be well-differentiated from Alzheimer's disease by measurement of brain acetylcholinesterase activity-[(11) C]MP4A PET study.

Bohnen NI, Müller ML, Kaufer DI.

Int J Geriatr Psychiatry. 2016 Aug;31(8):951-2. doi: 10.1002/gps.4373. Epub 2016 Mar 21. No abstract available.

38.

Interactive effects of age and multi-gene profile on motor learning and sensorimotor adaptation.

Noohi F, Boyden NB, Kwak Y, Humfleet J, Müller ML, Bohnen NI, Seidler RD.

Neuropsychologia. 2016 Apr;84:222-34. doi: 10.1016/j.neuropsychologia.2016.02.021. Epub 2016 Feb 27.

39.

Prevalence of impaired odor identification in Parkinson disease with imaging evidence of nigrostriatal denervation.

Haugen J, Müller ML, Kotagal V, Albin RL, Koeppe RA, Scott PJ, Frey KA, Bohnen NI.

J Neural Transm (Vienna). 2016 Apr;123(4):421-4. doi: 10.1007/s00702-016-1524-7. Epub 2016 Feb 24.

40.

Diabetes, Gray Matter Loss, and Cognition in the Setting of Parkinson Disease.

Petrou M, Davatzikos C, Hsieh M, Foerster BR, Albin RL, Kotagal V, Müller ML, Koeppe RA, Herman WH, Frey KA, Bohnen NI.

Acad Radiol. 2016 May;23(5):577-81. doi: 10.1016/j.acra.2015.07.014. Epub 2016 Feb 10.

41.

The Devil Is in the Details.

Rauen C, Gendrom-Trainer N, Muller ML.

Crit Care Nurse. 2015 Oct;35(5):68-72. doi: 10.4037/ccn2015735. No abstract available.

PMID:
26427977
42.

Striatal and Cortical β-Amyloidopathy and Cognition in Parkinson's Disease.

Shah N, Frey KA, Müller ML, Petrou M, Kotagal V, Koeppe RA, Scott PJ, Albin RL, Bohnen NI.

Mov Disord. 2016 Jan;31(1):111-7. doi: 10.1002/mds.26369. Epub 2015 Sep 18.

43.

Non-exercise physical activity attenuates motor symptoms in Parkinson disease independent from nigrostriatal degeneration.

Snider J, Müller ML, Kotagal V, Koeppe RA, Scott PJ, Frey KA, Albin RL, Bohnen NI.

Parkinsonism Relat Disord. 2015 Oct;21(10):1227-31. doi: 10.1016/j.parkreldis.2015.08.027. Epub 2015 Aug 28.

44.

VAMP8-dependent fusion of recycling endosomes with the plasma membrane facilitates T lymphocyte cytotoxicity.

Marshall MR, Pattu V, Halimani M, Maier-Peuschel M, Müller ML, Becherer U, Hong W, Hoth M, Tschernig T, Bryceson YT, Rettig J.

J Cell Biol. 2015 Jul 6;210(1):135-51. doi: 10.1083/jcb.201411093. Epub 2015 Jun 29.

45.

Educational attainment and motor burden in Parkinson's disease.

Kotagal V, Bohnen NI, Müller ML, Koeppe RA, Frey KA, Langa KM, Albin RL.

Mov Disord. 2015 Jul;30(8):1143-7. doi: 10.1002/mds.26272. Epub 2015 Jun 10.

46.

Imaging prodromal Parkinson disease: The Parkinson Associated Risk Syndrome Study.

Müller ML, Albin RL, Bohnen NI.

Neurology. 2015 Jun 2;84(22):2292. doi: 10.1212/WNL.0000000000001654. No abstract available.

PMID:
26033339
47.

Altered cerebellar connectivity in Parkinson's patients ON and OFF L-DOPA medication.

Festini SB, Bernard JA, Kwak Y, Peltier S, Bohnen NI, Müller ML, Dayalu P, Seidler RD.

Front Hum Neurosci. 2015 Apr 21;9:214. doi: 10.3389/fnhum.2015.00214. eCollection 2015.

48.

Amyloid deposition in Parkinson's disease and cognitive impairment: a systematic review.

Petrou M, Dwamena BA, Foerster BR, MacEachern MP, Bohnen NI, Müller ML, Albin RL, Frey KA.

Mov Disord. 2015 Jun;30(7):928-35. doi: 10.1002/mds.26191. Epub 2015 Apr 16. Review.

49.

Frequency of cholinergic and caudate nucleus dopaminergic deficits across the predemented cognitive spectrum of Parkinson disease and evidence of interaction effects.

Bohnen NI, Albin RL, Müller ML, Petrou M, Kotagal V, Koeppe RA, Scott PJ, Frey KA.

JAMA Neurol. 2015 Feb;72(2):194-200. doi: 10.1001/jamaneurol.2014.2757.

50.

Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease.

Bohnen NI, Kotagal V, Müller ML, Koeppe RA, Scott PJ, Albin RL, Frey KA, Petrou M.

Parkinsonism Relat Disord. 2014 Dec;20(12):1394-8. doi: 10.1016/j.parkreldis.2014.10.008. Epub 2014 Oct 15.

Supplemental Content

Loading ...
Support Center